The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Treatment of Herpes Zoster and Postherpetic Neuralgia

대상포진 및 대상포진후신경통 환자의 치료

  • Sim, Woo Seok (Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Choi, Jin Hwan (The Joun Pain Clinic) ;
  • Han, Kyung Ream (Department of Anesthesiology and Pain Medicine, College of Medicine, Ajou University) ;
  • Kim, Yong Chul (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine)
  • 심우석 (성균관대학교 의과대학 삼성서울병원 마취통증의학교실) ;
  • 최진환 (조은 통증크리닉) ;
  • 한경림 (아주대학교 의과대학 마취통증의학교실) ;
  • 김용철 (서울대학교 의과대학 마취통증의학교실)
  • Received : 2008.07.26
  • Accepted : 2008.07.31
  • Published : 2008.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Numerous treatment modalities for acute or subacute herpes zoster and postherpetic neuralgia have been introduced. Therefore, we updated the treatment modalities by conducting a wide review of the medical literature and we created a new treatment algorithm for herpes zoster and postherpetic neuralgia.

Keywords

References

  1. Jung BF, Johnson RW, Griffin DR, Dworkin RH: Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62: 1545-51 https://doi.org/10.1212/01.WNL.0000123261.00004.29
  2. Bowsher D: The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 1999; 3: 335-42 https://doi.org/10.1016/S1090-3801(99)90015-0
  3. Dworkin RH, Schmader KE: The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In:Herpes zoster and postherpetic neuralgia. 2nd ed. Edited by Watson CPN, Gershon AA: New York, Elsevier Press. 2001, pp 39-64
  4. Kashiwase M, Sata T, Yamauchi Y, Minoda H, Usui N, Iwasaki T, et al: Progressive outer retinal necrosis caused by herpes simplex virus type 1 in a patient with acquired immunodeficiency syndrome. Ophthalmology 2000; 107: 790-4 https://doi.org/10.1016/S0161-6420(99)00143-8
  5. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS: Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005; 2: e164 https://doi.org/10.1371/journal.pmed.0020164
  6. Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al: Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003; 26: 277-89 https://doi.org/10.1016/S1386-6532(03)00005-2
  7. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al: Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1): 1-26 https://doi.org/10.1086/505989
  8. Schmader K, George LK, Burchett BM, Pieper CF, Hamilton JD: Racial differences in the occurrence of herpes zoster. J Infect Dis 1995; 171: 701-4 https://doi.org/10.1093/infdis/171.3.701
  9. Galluzzi KE: Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2007; 107 (Suppl 1): 8-13
  10. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-53 https://doi.org/10.1128/AAC.39.7.1546
  11. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, et al: Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Collaborative famciclovir herpes zoster study group. Ann Intern Med 1995; 123: 89-96 https://doi.org/10.7326/0003-4819-123-2-199507150-00002
  12. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ: Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9: 863-9 https://doi.org/10.1001/archfami.9.9.863
  13. Wassilew S: Collaborative Brivudin PHN study group. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients: a randomized, double-blind, multinational study. J Eur Acad Dermatol Venereol 2005; 19: 47-55 https://doi.org/10.1111/j.1468-3083.2004.01119.x
  14. Decroix J, Partsch H, Gonzalez R, Mobacken H, Goh CL, Walsh L, et al: Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA). J Eur Acad Dermatol Venereol 2000; 14: 23-33 https://doi.org/10.1046/j.1468-3083.2000.00020.x
  15. Johnson RW: Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes 2007; 14(Suppl 2): 30-4
  16. Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al: Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebocontrolled trial. The national institute of allergy and infectious diseases collaborative antiviral study group. Ann Intern Med 1996; 125: 376-83 https://doi.org/10.7326/0003-4819-125-5-199609010-00004
  17. Dworkin RH, Schmader KE: Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 2003; 36: 877-82 https://doi.org/10.1086/368196
  18. Haanpaa M, Laippala P, Nurmikko T: Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J Pain Symptom Manage 2000; 20: 50-8 https://doi.org/10.1016/S0885-3924(00)00149-4
  19. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH: Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289-305 https://doi.org/10.1016/j.pain.2005.08.013
  20. Ray WA, Meredith S, Thapa PB, Hall K, Murray KT: Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004; 75: 234-41 https://doi.org/10.1016/j.clpt.2003.09.019
  21. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al: Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60: 1524-34 https://doi.org/10.1001/archneur.60.11.1524
  22. Eisenberg E, McNicol ED, Carr DB: Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005; 293: 3043-52 https://doi.org/10.1001/jama.293.24.3043
  23. Watson CP, Babul N: Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-41 https://doi.org/10.1212/WNL.50.6.1837
  24. Boureau F, Legallicier P, Kabir-Ahmadi M: Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebocontrolled trial. Pain 2003; 104: 323-31 https://doi.org/10.1016/S0304-3959(03)00020-4
  25. Berry JD, Petersen KL: A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005; 65: 444-7 https://doi.org/10.1212/01.WNL.0000168259.94991.8a
  26. Kuraishi Y, Takasaki I, Nojima H, Shiraki K, Takahata H: Effects of the suppression of acute herpetic pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in mice. Life Sci 2004; 74: 2619-26 https://doi.org/10.1016/j.lfs.2004.01.005
  27. Rowbotham MC, Young JP Jr, Sharma U: Pregabalin significantly reduces neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia by day 3 of treatment. In: Program and abstracts of neuropathic pain: changing paradigms in diagnosis and treatment. Edited by International Association for the Study of Pain Neuropathic Pain Special Interest Group: Seattle, IASP Press. 2004, p 48
  28. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84 https://doi.org/10.1056/NEJMoa051016
  29. Volpi A: Severe complications of herpes zoster. Herpes 2007; 14(Suppl 2): 35-9
  30. Balfour HH Jr, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, et al: Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 1983; 308: 1448-53 https://doi.org/10.1056/NEJM198306163082404
  31. Wutzler P, De Clercq E, Wutke K, Färber I: Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized doubleblind trial. J Med Virol 1995; 46: 252-7 https://doi.org/10.1002/jmv.1890460315
  32. Walton RC, Reed KL: Herpes zoster ophthalmicus following bone marrow transplantation in children. Bone Marrow Transplant 1999; 23: 1317-20 https://doi.org/10.1038/sj.bmt.1701796
  33. Gnann JW Jr, Crumpacker CS, Lalezari JP, Smith JA, Tyring SK, Baum KF, et al: Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative antiviral study group/aids clinical trials group, herpes zoster study group. Antimicrob Agents Chemother 1998; 42: 1139-45
  34. Watson CP: A new treatment for postherpetic neuralgia. N Engl J Med 2000; 343: 1563-5 https://doi.org/10.1056/NEJM200011233432110
  35. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al: Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007; 132: 237-51 https://doi.org/10.1016/j.pain.2007.08.033
  36. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324-34 https://doi.org/10.1056/NEJMoa042580
  37. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L: Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-42 https://doi.org/10.1001/jama.280.21.1837
  38. Rice AS, Maton S; Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001; 94: 215-24 https://doi.org/10.1016/S0304-3959(01)00407-9
  39. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, et al: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebocontrolled trial. Neurology 2003; 60: 1274-83 https://doi.org/10.1212/01.WNL.0000055433.55136.55
  40. Dick IE, Brochu RM, Purohit Y, Kaczorowski GJ, Martin WJ, Priest BT: Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 2007; 8: 315-24 https://doi.org/10.1016/j.jpain.2006.10.001
  41. Volmink J, Lancaster T, Gray S, Silagy C: Treatments for postherpetic neuralgia--a systematic review of randomized controlled trials. Fam Pract 1996; 13: 84-91 https://doi.org/10.1093/fampra/13.1.84
  42. Rowbotham MC, Reisner LA, Davies PS, Fields HL: Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain 2005; 6: 741-6 https://doi.org/10.1016/j.jpain.2005.07.001
  43. Wu CL, Raja SN: An update on the treatment of postherpetic neuralgia. J Pain 2008; 9(Suppl 1): 19-30
  44. Manfredi PL: Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003; 60: 1052-3
  45. Mao J, Chen LL: Systemic lidocaine for neuropathic pain relief. Pain 2000; 87: 7-17 https://doi.org/10.1016/S0304-3959(00)00229-3
  46. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC:The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 2002; 18: 297-301 https://doi.org/10.1097/00002508-200209000-00004
  47. Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R: Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol 2005; 252: 677-86 https://doi.org/10.1007/s00415-005-0717-z
  48. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR: Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 1999; 81: 135-45 https://doi.org/10.1016/S0304-3959(99)00007-X
  49. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ: Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004; 328: 991 https://doi.org/10.1136/bmj.38042.506748.EE
  50. Kochar DK, Garg P, Bumb RA, Kochar SK, Mehta RD, Beniwal R, et al: Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebocontrolled study. QJM 2005; 98: 29-34 https://doi.org/10.1093/qjmed/hci005
  51. Harding SP: Management of ophthalmic zoster. J Med Virol 1993; 40(Suppl 1): 97-101
  52. Zaal MJ, Volker-Dieben HJ, D'Amaro J: Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus. Graefes Arch Clin Exp Ophthalmol 2003; 241: 187-91 https://doi.org/10.1007/s00417-002-0609-1
  53. Shaikh S, Ta CN: Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician 2002; 66: 1723-30
  54. Pavan-Langston D: Viral disease of the ocular anterior segment: basic science and clinical disease. In: The cornea. 4th ed. Edited by Foster S, Azar D, Dohlman C: Philadelphia, Lippincott Williams & Wilkins. 2005, pp 297-397
  55. Gilbert SC: Bell's palsy and herpes viruses. Herpes 2002; 9: 70-3
  56. Murakami S, Hato N, Horiuchi J, Honda N, Gyo K, Yanagihara N: Treatment of Ramsay Hunt syndrome with acyclovir- prednisone: significance of early diagnosis and treatment. Ann Neurol 1997; 41: 353-7 https://doi.org/10.1002/ana.410410310
  57. De Diego JI, Prim MP, De Sarriá MJ, Madero R, Gavilán J: Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope 1998; 108: 573-5 https://doi.org/10.1097/00005537-199804000-00020
  58. Gnann JW Jr: Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002; 186(Suppl 1): 91-8 https://doi.org/10.1086/342963
  59. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al: Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000; 44: 910-8 https://doi.org/10.1034/j.1399-6576.2000.440803.x
  60. Higa K, Hori K, Harasawa I, Hirata K, Dan K: High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: comparison with effects of stellate ganglion block. Reg Anesth Pain Med 1998; 23: 25-9
  61. Hwang SM, Kang YC, Lee YB, Yoon KB, Ahn SK, Choi EH: The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol 1999; 135: 1359-64 https://doi.org/10.1001/archderm.135.11.1359
  62. Manabe H, Dan K, Higa K: Continuous epidural infusion of local anesthetics and shorter duration of acute zoster-associated pain. Clin J Pain 1995; 11: 220-8 https://doi.org/10.1097/00002508-199509000-00010
  63. Dureja GP, Bhalla AP: Multimodality regimen for the management of postherpetic neuralgia. Pain Clin 1991; 5: 15-9
  64. Lipton JR, Harding SP, Wells JC: The effect of early stellate ganglion block on postherpetic neuralgia in herpes zoster ophthalmicus. Pain Clin 1987; 1: 247-51
  65. Winnie AP, Hartwell PW: Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993; 18: 277-82
  66. Hardy D: Relief of pain in acute herpes zoster by nerve blocks and possible prevention of post-herpetic neuralgia. Can J Anaesth 2005; 52: 186-90 https://doi.org/10.1007/BF03027727
  67. Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A: Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999; 24: 287-93
  68. Kim JO, Lee MK, Kim JS, Kim DJ: Spinal cord stimulation for intractable postherpetic neuralgia. J Korean Neurosurg Soc 2003; 34: 366-8
  69. Dunteman E: Peripheral nerve stimulation for unremitting ophthalmic postherpetic neuralgia. Neuromodulation 2002; 5: 32-7 https://doi.org/10.1046/j.1525-1403.2002._2006.x

Cited by

  1. Spinal Cord Stimulation in the Treatment of Postherpetic Neuralgia in Patients with Chronic Kidney Disease: A Case Series and Review of the Literature vol.24, pp.3, 2011, https://doi.org/10.3344/kjp.2011.24.3.154
  2. Spinal Myoclonus Developed during Cervical Epidural Drug Infusion in Postherpetic Neuralgia Patient vol.24, pp.3, 2011, https://doi.org/10.3344/kjp.2011.24.3.169
  3. Survey on the Treatment of Postherpetic Neuralgia in Korea; Multicenter Study of 1,414 Patients vol.26, pp.1, 2013, https://doi.org/10.3344/kjp.2013.26.1.21
  4. Medications in Treatment of Postherpetic Neuralgia vol.27, pp.1, 2014, https://doi.org/10.3344/kjp.2014.27.1.1
  5. A Case Study of Soeumin patients with Herpes zosters vol.28, pp.4, 2015, https://doi.org/10.6114/jkood.2015.28.4.175
  6. Unilateral Abdominal Protrusion Developed in Diabetic Patient after Postherpetic Neuralgia vol.21, pp.3, 2008, https://doi.org/10.3344/kjp.2008.21.3.233
  7. Assessment of the Quality of Postherpetic Neuralgia Related Korean Internet Sites vol.22, pp.2, 2009, https://doi.org/10.3344/kjp.2009.22.2.141
  8. Zoster Paresis Misconceived as a Radiculopathy due to Herniated Intervertebral Disc vol.22, pp.2, 2009, https://doi.org/10.3344/kjp.2009.22.2.181
  9. An Open-Label Trial of the 5% Lidocaine Patches for the Treatment of Chronic Pain vol.22, pp.3, 2009, https://doi.org/10.3344/kjp.2009.22.3.216
  10. Superficial cervical plexus block for management of herpes zoster neuralgia in the C3 dermatome: a case report vol.8, pp.1, 2014, https://doi.org/10.1186/1752-1947-8-59
  11. 급성기 대상포진의 침구치료에 대한 임상 연구 문헌 고찰 vol.32, pp.3, 2008, https://doi.org/10.13045/acupunct.2015047
  12. Spinal segmental myoclonus improved with epidural blockade in a patient with herpes zoster radiculitis vol.19, pp.1, 2017, https://doi.org/10.14253/acn.2017.19.1.71
  13. Knotting of a Cervical Epidural Catheter in the Patient with Post-Herpetic Neuralgia: A Rare Complication vol.7, pp.1, 2008, https://doi.org/10.15280/jlm.2017.7.1.41
  14. 한방 치료로 호전된 대상포진 후 신경통 환자 치험 5례 vol.31, pp.3, 2008, https://doi.org/10.6114/jkood.2018.31.3.127
  15. 간호 분야 실무지침의 수용개작 방법론에 따른 통증간호 실무지침의 개발 vol.25, pp.1, 2019, https://doi.org/10.22650/jkcnr.2019.25.1.1
  16. 대상포진의 급성기 치료에 대한 국내 연구 현황 : 증례 보고 분석 vol.33, pp.1, 2020, https://doi.org/10.6114/jkood.2020.33.1.056
  17. Efficacy of continuous epidural infusion with epidural electric stimulation compared to that of conventional continuous epidural infusion for acute herpes zoster management: a retrospective study vol.20, pp.1, 2008, https://doi.org/10.1186/s12871-020-0950-0
  18. 국내 증례 보고를 통해 본 대상포진의 한방 단독 치료와 한·양방 협진 치료의 효과 분석 vol.34, pp.1, 2008, https://doi.org/10.6114/jkood.2021.34.1.044
  19. A Review of Korean Medicine Treatment for Postherpetic Neuralgia vol.38, pp.4, 2008, https://doi.org/10.13045/jar.2021.00171